Blog

Ensuring Quality & Compliance in Global Pharma Trade In the highly regulated world of B2B cross-border pharma trade, ensuring the quality, safety, and efficacy of pharmaceutical products is crucial. One of the most important documents that helps achieve this is the Certificate of Analysis (CoA). This document is essential for pharmaceutical bulk buyers, pharma distributors, […]

Malaria remains one of the biggest public health challenges in Africa, driving the constant demand for antimalarial drugs across the continent. With a significant portion of the world’s malaria cases occurring in Africa, the cross-border pharma trade plays a crucial role in ensuring a steady supply of these life-saving medicines. Companies like Pharmint, a leading

In cross-border B2B pharma trade, ensuring quality assurance is essential for the safety, efficacy, and regulatory compliance of medicines and medical supplies. International buyers face multiple challenges, from verifying supplier credibility to ensuring products meet stringent WHO-GMP, US FDA, and EU GMP standards. Pharmint, a leading B2B pharma marketplace in India, simplifies this process by

India has emerged as the global leader in contract manufacturing for the pharmaceutical industry, supplying high-quality, cost-effective medicines to regulated and semi-regulated markets worldwide. With increasing demand from Africa, Europe, Latin America, and the Middle East, contract manufacturing is fueling India’s dominance in B2B cross-border pharma trade. Leading B2B pharma marketplaces in India, like Pharmint,

The pharmaceutical industry is witnessing a massive shift, with digital transformation revolutionizing pharma wholesale distribution worldwide. Traditional medicine B2B wholesale India online models relied heavily on manual transactions, intermediaries, and outdated processes. Today, with B2B online wholesale medicine supply for pharmacy, buyers and sellers are experiencing faster, more transparent, and cost-effective trade solutions. Leading online

Why Biosimilars are Transforming the Global Pharmaceutical Market The biosimilars industry is experiencing rapid growth as healthcare systems worldwide seek cost-effective alternatives to expensive biologic drugs. With patent expirations of blockbuster biologics, the global demand for biosimilars is soaring, particularly in oncology, autoimmune diseases, diabetes, and cardiovascular conditions. For B2B pharma buyers, sourcing high-quality biosimilars

Pharmint: Simplifying Global Sourcing for Radiopharmaceuticals Radiopharmaceuticals, or radioactive drugs used for diagnosis and treatment, are experiencing significant global demand due to advancements in medical imaging and targeted therapies. With the rise of cancer treatments, nuclear medicine, and PET-CT scans, the need for high-quality radiopharmaceuticals is growing worldwide. As B2B pharma buyers, hospitals, and research